The Hepatic Sinusoid in Aging and Cirrhosis

The fenestrated sinusoidal endothelium (‘liver sieve’) and space of Disse in the healthy liver do not impede the transfer of most substrates, including drugs and oxygen, from the sinusoidal lumen to the hepatocyte. Plasma components transfer freely in both directions through the endothelial fenestrations and into the space of Disse. The endothelium is attenuated, there is no basement membrane and there is minimum collagen in the space of Disse, thus minimising any barriers to substrate diffusion.Both cirrhosis and aging are associated with marked structural changes in the sinusoidal endothelium and space of Disse that are likely to influence bulk plasma transfer into the space of Disse, and diffusion through the endothelium and space of Disse. These changes, termed capillarisation and pseudocapillarisation in cirrhosis and aging, respectively, impede the transfer of various substrates. Capillarisation is associated with exclusion of albumin, protein-bound drugs and macromolecules from the space of Disse, and the progressive transformation of flow-limited to barrier-limited distribution of some substrates.There is evidence that the sinusoidal changes in cirrhosis and aging contribute to hepatocyte hypoxia, thus providing a mechanism for the apparent differential reduction of oxygen-dependent phase I metabolic pathways in these conditions. Structural change and subsequent dysfunction of the liver sieve warrant consideration as a significant factor in the impairment of overall substrate handling and hepatic drug metabolism in cirrhosis and aging.

[1]  H. Popper,et al.  Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.

[2]  W. A. Day,et al.  High perfusion pressure damages the sieving ability of sinusoidal endothelium in rat livers. , 1980, British journal of experimental pathology.

[3]  Michael S Roberts,et al.  Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug. , 2002, The Journal of pharmacology and experimental therapeutics.

[4]  N. Hirooka,et al.  HEPATIC MICROCIRCULATION OF LIVER CIRRHOSIS STUDIED BY CORROSION CAST/SCANNING ELECTRON MICROSCOPE EXAMINATION , 1986, Acta pathologica japonica.

[5]  V. Rodighiero Effects of Liver Disease on Pharmacokinetics , 1999, Clinical pharmacokinetics.

[6]  P. J. Harvey,et al.  Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats. , 2000, The Journal of pharmacology and experimental therapeutics.

[7]  M. Roberts,et al.  Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver , 2002, Hepatology.

[8]  D. L. Le Couteur,et al.  Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. , 1999, The Journal of pharmacology and experimental therapeutics.

[9]  M. Rowland,et al.  Correlation between in‐vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model , 1986, The Journal of pharmacy and pharmacology.

[10]  P. J. Harvey,et al.  31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride‐treated rats , 1999, NMR in biomedicine.

[11]  J. Handler,et al.  Hepatobiliary function in senescent male sprague‐dawley rats , 1994, Hepatology.

[12]  G. Belforte,et al.  Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method. , 1998, The Journal of laboratory and clinical medicine.

[13]  H. Popper Aging and the liver. , 1986, Progress in liver diseases.

[14]  C. Rose,et al.  Flow‐limited tracer oxygen distribution in the isolated perfused rat liver: Effects of temperature and hematocrit , 1992, Hepatology.

[15]  C. Goresky,et al.  Transport, binding, and metabolism of sulfate conjugates in the liver. , 1994, Chemico-biological interactions.

[16]  H. Maeta,et al.  Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. , 2002, The Journal of surgical research.

[17]  P. Angus,et al.  Comparative effects of oxygen supplementation on theophylline and acetaminophen clearance in human cirrhosis. , 1999, Gastroenterology.

[18]  J. Henriksen,et al.  Alcoholic liver injury: Defenestration in noncirrhotic livers—a scanning electron microscopic study , 1987, Hepatology.

[19]  O Pelkonen,et al.  Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions , 1997, Clinical pharmacology and therapeutics.

[20]  A. Mclean,et al.  The Aging Liver , 1998, Clinical pharmacokinetics.

[21]  G. Rogers,et al.  Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis , 1995, Hepatology.

[22]  P. Angus,et al.  Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver. , 1996, Gastroenterology.

[23]  G. Koning,et al.  On the mechanism of hepatic transendothelial passage of large liposomes , 1999, FEBS letters.

[24]  J. Reichen The Role of the Sinusoidal Endothelium in Liver Function. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[25]  W. A. Day,et al.  Nicotine decreases the porosity of the rat liver sieve: a possible mechanism for hypercholesterolaemia. , 1988, British journal of experimental pathology.

[26]  D. Morgan,et al.  Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease , 1991, Hepatology.

[27]  E. Wisse,et al.  The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse , 1985, Hepatology.

[28]  A. Mclean,et al.  Age-Environment and Gene-Environment Interactions in the Pathogenesis of Parkinson's Disease , 2002, Reviews on environmental health.

[29]  G. Granneman,et al.  Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid Chromatography , 1995, Clinical pharmacokinetics.

[30]  R. Fraser,et al.  The transport of cholesterol in thoracic duct lymph of animals fed cholesterol with varying triglyceride loads. , 1969, The Australian journal of experimental biology and medical science.

[31]  D. Morgan,et al.  Clinical Pharmacokinetics in Patients with Liver Disease , 1991, Clinical pharmacokinetics.

[32]  F Varin,et al.  Hepatic microcirculation in the perfused cirrhotic rat liver. , 1985, The Journal of clinical investigation.

[33]  P. Richardson,et al.  Liver blood flow. II. Effects of drugs and hormones on liver blood flow. , 1981, Gastroenterology.

[34]  R. Branch,et al.  Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. , 1979, Gastroenterology.

[35]  G. Harms,et al.  Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules , 2004, Histochemistry.

[36]  J. Villeneuve,et al.  Hepatic circulation in cirrhosis. , 1985, Clinics in gastroenterology.

[37]  M. Anwer,et al.  Altered hepatobiliary transport of taurocholic acid in aged rats , 1980, Mechanisms of Ageing and Development.

[38]  D. P. Jones,et al.  Hypoxia and drug metabolism. , 1981, Biochemical pharmacology.

[39]  D. L. Le Couteur,et al.  Age‐related pseudocapillarization of the human liver , 2003, The Journal of pathology.

[40]  C. Florén Binding of apolipoprotein E-rich remnant lipoproteins to human liver membranes. , 1984, Scandinavian journal of gastroenterology.

[41]  D. L. Le Couteur,et al.  Carbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placenta. , 2003, Placenta.

[42]  R. Oxner,et al.  DEFENESTRATION OF HEPATIC SINUSOIDS AS A CAUSE OF HYPERLIPOPROTEINAEMIA IN ALCOHOLICS , 1988, The Lancet.

[43]  H. Wynne,et al.  Age-Related Changes in Liver Size and Hepatic Blood Flow , 1988 .

[44]  P. J. Harvey,et al.  Pseudocapillarization and associated energy limitation in the aged rat liver , 2001, Hepatology.

[45]  D. L. Schmucker Liver Function and Phase I Drug Metabolism in the Elderly , 2001, Drugs & aging.

[46]  W. Cliff,et al.  The effect of dietary fat load on the size and composition of chylomicrons in thoracic duct lymph. , 1968, Quarterly journal of experimental physiology and cognate medical sciences.

[47]  S. Pond,et al.  Aging, acute oxidative injury and hepatocellular glucose transport in the rat , 1995 .

[48]  R. Branch,et al.  Propranolol Disposition in Chronic Liver Disease: A Physiological Approach , 1976, Clinical pharmacokinetics.

[49]  Hydrodynamic effects on the solute transport across endothelial pores and hepatocyte membranes. , 2000, Physics in medicine and biology.

[50]  I. Wanless,et al.  Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies , 1996, Hepatology.

[51]  D. L. Le Couteur,et al.  Carbon monoxide wash-in method to determine gas transfer in vascular beds: application to rat hindlimb. , 2001, American journal of physiology. Heart and circulatory physiology.

[52]  D. L. Le Couteur,et al.  Carbon monoxide disposition in the perfused rat liver. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[53]  J. Villeneuve,et al.  Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple‐indicator dilution technique , 1993, Hepatology.

[54]  S. Dechambre,et al.  Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. , 2002, Clinical science.

[55]  A. Mclean,et al.  Hepatic sinusoidal pseudocapillarization with aging in the non-human primate , 2003, Experimental Gerontology.

[56]  M. Roberts,et al.  Structure-hepatic disposition relationships for phenolic compounds. , 1999, Toxicology and applied pharmacology.

[57]  L. Zocchi,et al.  Macromolecule transfer through mesothelium and connective tissue. , 2000, Journal of applied physiology.

[58]  Filip Braet,et al.  Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.

[59]  A. Mclean,et al.  Hepatic pseudocapillarisation and atherosclerosis in ageing , 2002, The Lancet.

[60]  C. Goresky,et al.  Uptake of materials by the intact liver. The exchange of glucose across the cell membranes. , 1974, The Journal of clinical investigation.

[61]  P. Ott,et al.  Interpretation of Simultaneous Measurements of Hepatic Extraction Fractions of Indocyanine Green and Sorbitol , 2000, Digestive Diseases and Sciences.

[62]  C. Goresky,et al.  A linear method for determining liver sinusoidal and extravascular volumes. , 1963, The American journal of physiology.

[63]  G. Geisslinger,et al.  Drug Acetylation in Liver Disease , 1998, Clinical pharmacokinetics.

[64]  Malcolm Rowland,et al.  Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[65]  C. Rose,et al.  Limitations of Tracer Oxygen Uptake in the Canine Coronary Circulation , 1985, Circulation research.

[66]  S. Lowden,et al.  Pathways of interstitial fluid and lymph flow in the liver acinus of the sheep and mouse , 1998, Journal of anatomy.

[67]  W. A. Day,et al.  Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. , 1978, Atherosclerosis.

[68]  T. Okanoue,et al.  Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis , 1993, Hepatology.

[69]  J. Villeneuve,et al.  The hepatic microcirculation in the isolated perfused human liver , 1996, Hepatology.

[70]  P. Angus,et al.  Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. , 1995, Gastroenterology.

[71]  B. Rippe,et al.  Transendothelial Transport: The Vesicle Controversy , 2002, Journal of Vascular Research.

[72]  D. Morgan,et al.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease , 1995, Clinical pharmacokinetics.

[73]  Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[74]  J S Harmatz,et al.  Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly , 1991, Clinical pharmacokinetics.

[75]  Michael S. Roberts,et al.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[76]  J S Harmatz,et al.  Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly , 2012, Clinical pharmacokinetics.

[77]  C. Goresky,et al.  On the uptake of materials by the intact liver. The transport and net removal of galactose. , 1973, The Journal of clinical investigation.

[78]  J. Villeneuve,et al.  Assessment of liver microcirculation in human cirrhosis. , 1982, The Journal of clinical investigation.

[79]  M. Bendayan Vascular permeability in blood capillary , 2002, Microscopy research and technique.

[80]  W. Cherry,et al.  Uptake of a protein‐bound polar compound, acetaminophen sulfate, by perfused rat liver , 1992, Hepatology.

[81]  T. Okanoue,et al.  Role of sinusoidal endothelial cells in liver disease , 1995, Journal of gastroenterology and hepatology.

[82]  P. Angus,et al.  Effect of cirrhosis on sulphation by the isolated perfused rat liver. , 1999, Journal of hepatology.

[83]  J. Villeneuve,et al.  Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat , 1993, Hepatology.

[84]  D. L. Le Couteur,et al.  The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. , 1994, Transplantation.